RVNC
Closed
Revance The
3.65
0.00 (0.00%)
Last Update: 07 Feb 2025 00:00:00
Yesterday: 3.65
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
31.47
Revance Therapeutics is a biotechnology company that develops and commercializes innovative products for the aesthetic and therapeutic markets. The company's proprietary technology platform, called the RHA® Collection, is designed to create a more natural-looking aesthetic result by mimicking the natural movements of facial muscles. Revance's lead product candidate, DaxibotulinumtoxinA for Injection (DAXI), is a next-generation neuromodulator that has the potential to be a longer-lasting alternative to existing botulinum toxin products. The company is also developing a range of other products, including injectable dermal fillers, topical skincare products, and treatments for various medical conditions. Revance is headquartered in Newark, California, and was founded in 2002.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








